Literature DB >> 16499751

Decrease of hippocampal GABA B receptor-mediated inhibition after hyperthermia-induced seizures in immature rats.

Min-Lan Tsai1, L Stan Leung.   

Abstract

PURPOSE: Whether febrile seizures have detrimental consequences on the brain is still controversial. We hypothesized that neuronal inhibition in the hippocampus is altered after hyperthermia-induced seizures in immature rats.
METHODS: Rats were given a single seizure by a heat lamp on postnatal day (PND) 15, or repeated seizures by heated air on PND 13 to 15. Fourteen or 30 days after the seizure(s), laminar field potentials were recorded by 16-channel silicon probes in CA1 and the dentate gyrus (DG), in response to the paired-pulse stimulation of the CA3 and medial perforant path, and analyzed as current source density. Gamma-aminobutyric acid (GABA)(B)-receptor antagonist CGP35348 was injected intracerebroventricularly (icv).
RESULTS: At 14 but not at 30 days after a single or after repeated hyperthermia-induced seizures, paired-pulse facilitation (PPF) of the CA1 population spikes at 100 to 200 ms interpulse intervals (IPIs) was significantly increased in seizure as compared with control rats, irrespective of the types of induced seizures. CGP35348 icv also resulted in PPF at 100 to 200 ms IPIs in CA1 of control rats, but CGP35348 had no effect on PPF in seizure rats. At 30 days after repeated seizures, paired-pulse inhibition in the DG was significantly increased at 30-ms IPI, and PPF was increased at 200-ms IPI. CGP35348 increased paired-pulse inhibition in the DG in repeated-seizure rats but not in control rats.
CONCLUSIONS: We conclude that hyperthermia-induced seizures in immature rats induced a decrease of GABA(B) receptor-mediated inhibition in CA1 and DG that lasted > or =14 to 30 days after hyperthermic seizure(s).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16499751     DOI: 10.1111/j.1528-1167.2006.00419.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  8 in total

1.  A novel zebrafish model of hyperthermia-induced seizures reveals a role for TRPV4 channels and NMDA-type glutamate receptors.

Authors:  Robert F Hunt; Gabriela A Hortopan; Anna Gillespie; Scott C Baraban
Journal:  Exp Neurol       Date:  2012-06-24       Impact factor: 5.330

2.  Biphasic modulation of parallel fibre synaptic transmission by co-activation of presynaptic GABAA and GABAB receptors in mice.

Authors:  Rebecca D Howell; Jason R Pugh
Journal:  J Physiol       Date:  2016-05-29       Impact factor: 5.182

3.  Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats.

Authors:  M A Galic; K Riazi; A K Henderson; S Tsutsui; Q J Pittman
Journal:  Neurobiol Dis       Date:  2009-08-04       Impact factor: 5.996

Review 4.  Generation of Febrile Seizures and Subsequent Epileptogenesis.

Authors:  Bo Feng; Zhong Chen
Journal:  Neurosci Bull       Date:  2016-08-25       Impact factor: 5.203

5.  Synaptic plasticity in the hippocampus of a APP/PS1 mouse model of Alzheimer's disease is impaired in old but not young mice.

Authors:  Simon Gengler; Alison Hamilton; Christian Hölscher
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

Review 6.  Fever, febrile seizures and epilepsy.

Authors:  Céline M Dubé; Amy L Brewster; Cristina Richichi; Qinqin Zha; Tallie Z Baram
Journal:  Trends Neurosci       Date:  2007-09-25       Impact factor: 13.837

7.  Loss of Leptin-Induced Modulation of Hippocampal Synaptic Trasmission and Signal Transduction in High-Fat Diet-Fed Mice.

Authors:  Marco Mainardi; Matteo Spinelli; Federico Scala; Andrea Mattera; Salvatore Fusco; Marcello D'Ascenzo; Claudio Grassi
Journal:  Front Cell Neurosci       Date:  2017-07-28       Impact factor: 5.505

8.  Neuroprotective effects of D-Ala(2)GIP on Alzheimer's disease biomarkers in an APP/PS1 mouse model.

Authors:  Emilie Faivre; Christian Hölscher
Journal:  Alzheimers Res Ther       Date:  2013-04-19       Impact factor: 6.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.